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Varicella and MMRV Orders 
On May 19th, the Morbidity and Mortality 
Weekly Report (MMWR) dispatch was 
published regarding limited supply of 
meningococcal conjugate vaccine 
(Menactra) and recommendations to defer 
vaccination of individuals 11-12 years of 
age.  Sanofi Pasteur anticipates that MCV4 
demand will outpace supply at least through 
summer 2006.  The MMWR recommends 
that providers continue to vaccinate 
adolescents at high school entry who have 
not previously received MCV4 and college 
freshmen living in dormitories.  Current 
supply projections from Sanofi Pasteur 
suggest that enough MCV4 will be available 
to meet vaccine demand for these groups. 
Until further notice, administration of MCV4 
to persons aged 11-12 years should be 
deferred.  If possible, providers should track 
persons aged 11-12 years for whom MCV4 
has been deferred and recall them for 
vaccination when supply improves.   A 
complete copy of the MMWR is available at  
http://www.cdc.gov/mmwr/preview/mmwrht
ml/mm55d520a1.htm?s_cid=mm55d520a1e 
Limited Menactra Supply - Defer Vaccination of 11-12 Year Olds  
Beginning May 22, 2006, the process of 
ordering VFC varicella and MMRV 
vaccine was changed.  These two vaccines  
have been incorporated into the regular 
VFC “Vaccine Order Form” for non-IRIS 
users and included in the IRIS online 
ordering feature for IRIS users.  VFC 
Program providers no longer need to use 
the “Varicella Vaccine Order Form” and 
all remaining copies should be discarded.   
 
Providers should continue to administer 
single dose MMR and varicella vaccine 
before placing orders for MMRV to ensure 
vaccine is not wasted. 
 
Varicella and MMRV vaccine will be 
distributed directly from Merck, the 
vaccine manufacturer.  The Immunization 
Program will not maintain these products 
in the state’s inventory due to handling and 
distribution temperature requirements.  
These products will be shipped separately 
for other state supplied vaccines.   
IRIS users that have questions regarding 
the online ordering of these vaccines 
should contact the IRIS Help Desk at 1-
800-374-3958.   
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This newsletter is a quarterly 
publication and contains 
important updates and 
immunization information.  
Please share this newsletter 
with your coworkers.   
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2006 Regional  
Trainings Cancelled 
The regional trainings for the 2006 Immuniza-
tion Update have been cancelled due to the 
mumps outbreak in Iowa.   The Immunization 
Program regrets any inconveniences this has 
caused anyone.  Participants should contact 
the entity they registered with for reimburse-
ment.   
 
Enclosed with this newsletter is a CD titled 
“2006 Immunization Update”  which contains 
all the information that was to be presented at 
the trainings.     
 
The content of the CD is valuable for any 
practice providing immunizations.  It high-
lights many areas of immunizations including: 
Chapter 7 of the Iowa Administrative Code, 
the Iowa Guide to the Immunization Law, 
ACIP recommendations, Vaccine Information 
Statements, the CDC “Pink Book,” immuni-
zation certificates, and more.   
 
All of the information contained on the CD is 
public and clinics are free to make copies as 
needed. 
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The Vaccines for Children (VFC) 
Program provides publicly purchased 
vaccine at no charge to enrolled public 
and private health care providers to 
vaccinate eligible children. Children, 
birth through 18 years of age, are 
eligible if they meet one of the 
following criteria:   
Medicaid enrolled - a child who is 
enrolled in the Medicaid program.   
This includes individuals that have 
Medicaid as secondary insurance 
coverage.    
Uninsured - a child who has no health 
insurance coverage. 
American Indian or Alaskan Native 
as defined by the Indian Health 
Services Act. 
Underinsured - a child whose health 
insurance benefit plan does not 
include vaccinations. Underinsured 
children are eligible to receive VFC 
vaccine only if they are served by a 
Federally Qualified Health Center 
(FQHC), Rural Health Clinic (RHC) 
or Local Public Health Agency 
(LPHA). 
 
Underinsured children are defined as 
those children who have health 
insurance but coverage does not 
include vaccines. Children whose 
health insurance cover only select 
vaccines or caps the vaccine cost at a 
certain limit are categorized as 
underinsured; thus only eligible for 
VFC program benefits at an FQHC, 
RHC, or LPHA.  
 
Children whose health insurance covers 
the cost of vaccinations are not eligible 
for VFC program benefits, even when  
the plan’s deductible has not been met.  
 
hawk-i (Healthy and Well Kids in 
Iowa) enrolled children are not VFC-
eligible because they are considered 
insured.  
 
 
 
New Recommended Vaccines 
and Covered Age Ranges for 
the VFC Program  
 
The Iowa Vaccines for Children 
Program (VFC) is making the 
following changes regarding newly 
licensed and recommended vaccines 
and covered age ranges.  The following 
changes will be effective June 5, 2006.   
 
Meningococcal Conjugate-Menactra 
(MCV4) 
Menactra will be expanded to include 
VFC eligible children from 11 through 
18 years of age*. Previously, the VFC 
Program only covered children 11-12 
years of age and 17-18 year old college 
freshmen living in dorms.   
 
Tetanus, diphtheria, acellular 
pertussis (Tdap)  
The use of Tdap will be expanded to 
include VFC eligible children 10-18 
years of age.  Tdap vaccines may be 
administered through the VFC Program 
as follows:  
Adacel (Sanofi)  11-18 years of age 
Boostrix (GSK)  10-18 years of age 
Previously, the VFC Program only 
covered children 11-12 years of age. 
 
Hepatitis A  
On October 27, 2005, the Advisory 
Committee on Immunization Practices 
(ACIP) voted to recommend the routine 
use of hepatitis A vaccine for all 
children 12-23 months of age.  The 
Iowa VFC Program will provide 
hepatitis A vaccine for children 12-23 
months of age.  The recommended 
schedule for hepatitis A vaccine is to 
provide dose one at 12 months of age 
and dose two 6-18 months later.  Any 
VFC-eligible child who began the two 
dose series between 12-23 months of 
age may complete the series at any age 
using VFC vaccine if the child is still 
VFC eligible.  Individuals requesting 
hepatitis A vaccine outside of the 12-23 
months of age will need to be 
vaccinated with privately purchased 
vaccine.  Providers that administer 
hepatitis A vaccine to Medicaid-
enrolled patients who are outside of the 
covered cohort may seek 
reimbursement from Medicaid.  
Medicaid will reimburse providers a 
maximum of $29.52 for the vaccine 
and $4.95 for administration. 
 
Measles, mumps, rubella, varicella 
(MMRV) 
On October 27, 2005, the ACIP voted 
to recommend the routine use of 
measles, mumps, rubella, and varicella 
(MMRV) combination vaccine as a 
single dose for VFC-eligible children 
12 months to 12 years of age.  MMRV 
should not be administered for the 
second dose of MMR except when a 
dose of varicella is also indicated.  
Providers should continue to administer 
single dose MMR and varicella before 
placing an order for MMRV to ensure 
that vaccine is not wasted.  Orders for 
MMRV may be reduced or denied if 
provider inventories contain large 
amounts of MMR and varicella 
vaccine. 
 
Rotavirus 
On February 22, 2006, the ACIP voted 
to recommend the routine use of 
rotavirus vaccine for infants aged 6 
weeks through 32 weeks.  The 
recommended schedule for rotavirus is 
to provide dose one at 2 months of age, 
dose two at 4 months of age and dose 
three at 6 months of age.  The first dose 
of rotavirus vaccine should be initiated 
for infants between 6 and 12 weeks of 
age with two additional doses 
administered at 4-10 week intervals.  
The last dose of rotavirus vaccine 
should be administered by 32 weeks of 
age. 
 
* See limited Menactra supply 
article on page 1. 
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In March 2006, providers across the 
state were sent the “Recommendation 
Alert for Hepatitis B.”  This quick 
reference guide was designed to give 
clinic staff and providers an “at a 
glance” summary of the 
recommendations to eliminate 
transmission of Hepatitis B as put forth 
in the December 23, 2005 issue of the 
MMWR.   An additional copy of the 
document is included with the 
newsletter.   
 
The Recommendation Alert is 
available on the Iowa Department of 
Public Health’s website: 
www.idph.state.ia.us/adper/common/p
df/hepatitis/hep_b_alert_march_2006.p
df.   
 
For questions regarding Maternal 
Hepatitis B please contact Bridget 
Konz, RN at 1-800-831-6293 ext. 7  
By adopting this policy change, VFC 
providers will assist IDPH in its 
stewardship of the limited VFC dollars 
our state receives.  
  
If you have questions about the VFC 
program please contact Tina Patterson 
at 1-800-831-6293 ext. 4. 
 
 
Influenza vaccine orders will be 
distributed this fall once product is 
available.  The manufacturers distribute 
influenza vaccine as it is produced and 
released by the Food and Drug 
Administration (FDA).  As in past 
years, influenza vaccine will be 
distributed in partial shipments to allow 
all providers to receive a portion of 
their vaccine order prior to the 
beginning of the influenza season.   
If your clinic has missed the VFC 
influenza pre-booking deadline, please 
contact Tina Patterson, VFC Program 
Coordinator at 1-800-831-6293 ext. 4. 
In February 2006, the Advisory 
Committee on Immunization Practices 
voted to expand the VFC influenza 
vaccine resolution to include all VFC 
eligible children 6 months through 18 
years.   
 
The Centers for Disease Control and 
Prevention (CDC) has established 
federal vaccine contracts for influenza 
vaccine with Sanofi Pasteur, Chiron, 
and MedImmune Vaccines.  The 
amount of influenza vaccine available 
from the CDC contracts may not be 
sufficient to meet the need of all states.  
IDPH cannot guarantee providers will 
receive specific influenza products 
other than FluMist.   
2006-07 VFC Influenza Vaccine  
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Hepatitis B:  Pediarix, Comvax and the VFC Program  
As indicated on the 2006-Childhood and 
Adolescent Immunization Schedule it is 
permissible to administer 4 doses of Hepa-
titis B vaccine when combination vaccines 
(Comvax or Pediarix) are given after the 
birth dose.   
 
While this is an allowable schedule, it is 
not the best use of the VFC Program 
funds.   The VFC dollars available to Iowa 
are limited, and IDPH strives to work with 
providers to vaccinate as many children as 
possible with a limited budget.  By using 
single antigen vaccine, when possible, it 
will allow IDPH and VFC providers to 
stretch the limited dollars to keep more 
Iowa children healthy.    
 
VFC clinics should stock single antigen 
vaccine, such as hepatitis B, to allow for 
the most cost effective administration of 
VFC vaccine.  If monovalent Hepatitis B 
vaccine is used, a dose at 4 months of age 
is not necessary.  The following table  
illustrates the cost savings achieved  by 
using single antigen vaccine when possi-
ble.   
The IDPH VFC program suggests VFC 
providers review their current policy to 
determine if this cost saving technique is 
appropriate for their clinic.    
Combination Hepatitis B 
Containing Vaccine -  
Price Comparison  
Hib $7.92 - $10.62 per dose 
Hep B  $9.10 
Total  $17.02 - $19.72 
Comvax  $26.25 
Savings  $6.53 -  $9.23 
DTap  $12.25 –$13.25 
Hep B  $9.10 
e-IPV  $10.82 
Total  $32.17-$33.17 
Pediarix  $43.75 
Savings  $10.58 - $11.58 
If you have any questions or concerns re-
garding the on-line ordering please contact 
the IRIS Help Desk at 1-800-374-3958.  
Help Desk staff is available Monday-
Friday, 7:30-4:30 p.m. 
IRIS Help is a Call Away 
Rotavirus Vaccine Recommended for Infants   
previous dose of vaccine. Precautions 
were recommended for children who 
have experienced intussusception in the 
past or have either T or B cell 
deficiency.  There is a theoretical risk 
that the live virus vaccine can be 
transmitted to non-vaccinated contact.  
The potential  risk of transmission of 
vaccine virus should be weighed 
against the risk of acquiring and 
transmitting natural rotavirus.   
 
A large-scale clinical trial the 
Rotavirus Efficacy and Safety Trial 
(REST) involved more than 68,000 
infants who were followed through two 
years of age.  Researchers reported no 
significant adverse events or 
complications.  The vaccine is well 
tolerated with respect to all adverse 
experiences, including intussusception, 
with some mild increase in vomiting, 
and diarrhea. 
 
The vaccine should be stored in the 
refrigerator 35-46o F (2-8o C), protected 
from light, administered as soon as 
possible after removing from 
refrigerator and the plastic tube 
discarded in an approved bio-waste 
container. 
human serotypes that cause the most 
rotavirus disease worldwide: G1, G2, 
G3, G4 and P1.  Each dose is supplied 
in a ready to use squeezable plastic 
latex-free dosing tube.   
 
The first dose is recommended for 
infants between 6 and 12 weeks of age, 
with a four to 10-week interval 
between the three doses.  All doses are 
recommended to be completed by 32 
weeks of age. 
 
The vaccine can be given with other 
vaccines given at 2, 4, and 6 months of 
age.  There are no restrictions on the 
infants’ consumption of food or liquid, 
including breast milk, either before or 
after vaccination.  Infants who 
regurgitate the vaccine should not 
receive another administration of that 
dose.   
 
Premature infants who are clinically 
stable, at least 6 weeks old and are 
going to be or have been discharged 
from the nursery, can receive the 
vaccine. 
 
The vaccine is not recommend for 
children who have serious allergies to 
any vaccine component or to a 
The Advisory Committee on 
Immunization Practices (ACIP) 
recommended universal immunization 
for infants at 2, 4 and 6 months of age 
with the newly approved live, oral, 
pentavalent rotavirus vaccine (PRV; 
RotaTeq, Merck). 
 
Virtually all children experience 
rotavirus.  Every year in the United 
States 2.7 million children are infected 
with rotavirus:  500,000 visit their 
physicians, 250,000 visit emergency 
departments, 55,000 to 70,000 are 
hospitalized and 40-60 die.  During the 
winter months, rotavirus infections are 
one of the most common reasons for 
children to be hospitalized.  About 
20% of all first-time rotavirus 
infections are moderate to severe with 
the infant quickly becoming 
dehydrated due to persistent vomiting, 
diarrhea and the difficulty of orally 
rehydrating an infant. 
 
The licensure of RotaTeq provides an 
opportunity to prevent, not treat, 
rotavirus.  The vaccine has a 74% 
efficacy against any disease, and 98-
100% efficacy against severe disease.  
The vaccine is an oral liquid (live-
attenuated) that contains the five 
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New Immunization 
Brochure and Poster 
The Immunization Program is proud to 
announce the arrival of a new 
immunization poster and several 
brochures.  The poster and brochures  
include  Iowa’s new slogan 
“Immunize for a Better Life.”   
 
There are two topic specific brochures 
focusing on influenza and the Iowa 
Immunization Law, and there are three 
brochures focusing on appropriate 
immunizations for infants, 
adolescents, and adults.   
 
The brochures are free and are 
available by calling the Clearinghouse 
at 1-888-398-9696. 
It is not too late to watch CDC's 
annual four-part broadcast Epidemiology 
and Prevention of Vaccine-Preventable 
Diseases.  
 
The four-part broadcast is now available 
in two formats; internet-based program 
or DVD. The internet version can be 
found at: 
http://www.phppo.cdc.gov/PHTN//webc
ast/epv06/default.asp  
  
The DVD can be ordered using the 
online order form found at: 
http://www.cdc.gov/nip/publications/def
ault.htm  The four-part series is the last 
item listed on the "CDC Online Order 
Form."  
CDC Four Part  
 Broadcast  
Useful Websites for  
Immunization Providers 
 
Centers for Disease Control and 
Prevention / National  
Immunization Program 
www.cdc.gov/nip   
 
The Immunization Action Coalition 
www.immunize.org 
 
Children’s Hospital of Philadelphia  
www.vaccine.chop.edu  
 
American Academy of Pediatrics 
www.aap.org 
 
Iowa Immunization Program 
www.idph.state.ia.us/adper/
immunization.asp 
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